Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature R Galhardoni, GS Correia, H Araujo, LT Yeng, DT Fernandes, ... Archives of physical medicine and rehabilitation 96 (4), S156-S172, 2015 | 164 | 2015 |
Normative data of cortical excitability measurements obtained by transcranial magnetic stimulation in healthy subjects AS Cueva, R Galhardoni, RG Cury, DC Parravano, G Correa, H Araujo, ... Neurophysiologie Clinique/Clinical Neurophysiology 46 (1), 43-51, 2016 | 59 | 2016 |
Outcomes of TP53 mutated AML with evolving frontline therapies: impact of allogeneic stem cell transplantation on survival MD Patel, Y Abaza, JP Bewersdorf, AN Saliba, GSDC Correia, A Duvall, ... | 25 | 2022 |
Estimulação magnética transcraniana e aplicabilidade clínica: perspectivas na conduta terapêutica neuropsiquiátrica HA Araújo, RF Iglesio, GS de Camargo Correia, DTRM Fernandes, ... Revista de Medicina 90 (1), 3-14, 2011 | 24 | 2011 |
Addressing a new challenge in chronic lymphocytic leukemia: outcomes of therapies after exposure to both a covalent Bruton's tyrosine kinase inhibitor and venetoclax MC Thompson, LE Roeker, CC Coombs, JL Jensen, M Kamdar, ... Blood 138, 2628, 2021 | 12 | 2021 |
Emerging targeted therapies in advanced non-small-cell lung cancer S Li, GS de Camargo Correia, J Wang, R Manochakian, Y Zhao, Y Lou Cancers 15 (11), 2899, 2023 | 7 | 2023 |
Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study S Handa, M Sterpi, G Sacchi De Camargo Correia, DS Frankel, Y Beilin, ... Blood Advances 7 (10), 1967-1975, 2023 | 4 | 2023 |
Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia T Badar, MR Litzow, RM Shallis, A Patel, AN Saliba, M Burkart, ... Cancer 129 (6), 934-945, 2023 | 3 | 2023 |
Multicenter analysis of treatment and outcomes for patient with TP53 mutated AML in the era of novel therapies; significant impact of allogeneic stem cell transplantation on … T Badar, MR Litzow, RM Shallis, JP Bewersdorf, A Saliba, M Stahl, ... Blood 138, 797, 2021 | 3 | 2021 |
Primary pulmonary NUT carcinoma: case illustration and updated review of literature BA Costa, A Maraveyas, MH Wilkoff, GS de Camargo Correia, PT de Lara, ... Clinical Lung Cancer 23 (4), e296-e300, 2022 | 2 | 2022 |
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid … T Badar, A Nanaa, E Atallah, RM Shallis, SCC Guilherme, AD Goldberg, ... Blood Cancer Journal 14 (1), 32, 2024 | 1 | 2024 |
Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis T Fujisaki, D Sueta, E Yamamoto, C Buckley, ... Cardio Oncology 6 (1), 99-113, 2024 | 1 | 2024 |
Estimulação magnética transcraniana e aplicabilidade clínica: perspectivas na conduta terapêutica neuropsiquiátrica HA Araújo, RF Iglesio, GSC Correia, MA Marcolim, MJ Teixeira, ... Revista de Medicina 89 (supl.), 13, 2010 | 1 | 2010 |
The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer GS de Camargo Correia, Y Zhao, R Manochakian, Y Lou Frontiers in Oncology 14, 2024 | | 2024 |
Achievement of Undetectable BCR:: ABL1 (uBCR:: ABL1) Is Predictive of Improved Survival in Philadelphia Chromosome Positive (Ph+ ve) Acute Lymphoblastic Leukemia (ALL) Patients … T Badar, R Narra, A Mims, RM Shallis, GSDC Correia, C Hunter, VK Kota, ... Blood 142, 1464, 2023 | | 2023 |
Comparable Survival of Treatment Naïve TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy T Badar, EL Atallah, RM Shallis, AA Patel, GSDC Correia, AD Goldberg, ... Blood 142, 592, 2023 | | 2023 |
Uptake of palliative care services in patients with non-small cell lung cancer receiving immune checkpoint inhibitor therapy: The Mayo Clinic Florida experience. T Pai, S Li, G Sacchi de Camargo Correia, OM Mosalem, NE Wiest, ... JCO Oncology Practice 19 (11_suppl), 269-269, 2023 | | 2023 |
Immune-Related Adverse Events in Patients with Lung Cancer G Sacchi de Camargo Correia, T Pai, S Li, D Connor, Y Zhao, Y Lou, ... Current oncology reports 25 (11), 1259-1275, 2023 | | 2023 |
P354: MULTI-INSTITUTIONAL STUDY EVALUATING THE IMPACT ON SURVIVAL OF NEWER TREATMENT COMBINATIONS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PHILADELPHIA CHROMOSOME POSITIVE … T Badar, E Atallah, R Narra, A Mims, V Kota, S Desai, ... HemaSphere 7 (S3), e9392932, 2023 | | 2023 |
Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer. B McKinley, S Li, N Wiest, E Butts, T Pai, J Wang, OM Mosalem, ... Journal of Clinical Oncology 41 (16_suppl), e21156-e21156, 2023 | | 2023 |